On the use of IMAGE FUV for estimating the latitude of the open/closed magnetic field line boundary in the ionosphere

first_imgA statistical comparison of the latitude of the open/closed magnetic field line boundary (OCB) as estimated from the three far ultraviolet (FUV) detectors onboard the IMAGE spacecraft (the Wideband Imaging camera, WIC, and the Spectrographic Imagers, SI-12 and SI-13) has been carried out over all magnetic local times. A total of over 400 000 OCB estimations were compared from December 2000 and January and December of 2001–2002. The modal latitude difference between the FUV OCB proxies from the three detectors is small, <1°, except in the predawn and evening sectors, where the SI-12 OCB proxy is found to be displaced from both the SI-13 and WIC OCB proxies by up to 2° poleward in the predawn sector and by up to 2° equatorward in the evening sector. Comparing the IMAGE FUV OCB proxies with that determined from particle precipitation measurements by the Defense Meteorological Satellites Program (DMSP) also shows systematic differences. The SI-12 OCB proxy is found to be at higher latitude in the predawn sector, in better agreement with the DMSP OCB proxy. The WIC and SI-13 OCB proxies are found to be in better agreement with the DMSP OCB proxy at most other magnetic local times. These systematic offsets may be used to correct FUV OCB proxies to give a more accurate estimate of the OCB latitude.last_img read more

Subduction over the Southern Indian Ocean in a high-resolution atmosphere-ocean coupled model

first_imgThis study examines the subduction of the Subantarctic Mode Water in the Indian Ocean in an ocean–atmosphere coupled model in which the ocean component is eddy permitting. The purpose is to assess how sensitive the simulated mode water is to the horizontal resolution in the ocean by comparing with a coarse-resolution ocean coupled model. Subduction of water mass is principally set by the depth of the winter mixed layer. It is found that the path of the Agulhas Current system in the model with an eddy-permitting ocean is different from that with a coarse-resolution ocean. This results in a greater surface heat loss over the Agulhas Return Current and a deeper winter mixed layer downstream in the eddy-permitting ocean coupled model. The winter mixed layer depth in the eddy-permitting ocean compares well to the observations, whereas the winter mixed layer depth in the coarse-resolution ocean coupled model is too shallow and has the wrong spatial structure. To quantify the impacts of different winter mixed depths on the subduction, a way to diagnose local subduction is proposed that includes eddy subduction. It shows that the subduction in the eddy-permitting model is closer to the observations in terms of the magnitudes and the locations. Eddies in the eddy-permitting ocean are found to 1) increase stratification and thus oppose the densification by northward Ekman flow and 2) increase subduction locally. These effects of eddies are not well reproduced by the eddy parameterization in the coarse-resolution ocean coupled model.last_img read more

Kentucky Derby winner Country House will not race in Preakness Stakes due to health

first_img Beau Lund May 7, 2019 /Sports News – National Kentucky Derby winner Country House will not race in Preakness Stakes due to health Written bycenter_img FacebookTwitterLinkedInEmailAndy Lyons/Getty Images(NEW YORK) — This year’s Kentucky Derby winner, Country House, will not race in the Preakness Stakes due to health concerns, according to his trainer.The champion horse is currently coughing and his blood profile is not normal, his trainer, Bill Mott, told ABC News. The Preakness Stakes, the second round of the Triple Crown, is set for May 18.Country House was determined the Derby winner when a controversial decision disqualified Maximum Security, the first horse to cross the finish line, after a review found Maximum Security veered out of his path on the final turn.An appeal filed by Maximum Security’s owners was denied by the Kentucky Horse Racing Commission.Additional details on Country House’s health were not immediately available.Copyright © 2019, ABC Radio. All rights reserved.last_img read more

Prep Sports Roundup: 8/22

first_img Written by FacebookTwitterLinkedInEmailGirls SoccerRegion 14MANTI, Utah-Megan Olson found the net twice and the Manti Templars blanked the Delta Rabbits 5-0 Thursday in Region 14 girls soccer action. Ally Squire, Brynlee Golding and Kassidy Alder also scored for Manti in the win. Katie Larsen earned the shutout for the Templars.NEPHI, Utah-Josephine Kay and Katie Cowan each found the net as the Juab Wasps doubled up Union 2-1 in Region 14 girls soccer action Thursday.SPANISH FORK, Utah-North Sanpete and American Leadership Academy finished their Region 14 match in a 2-2 draw Thursday.Non-RegionFILLMORE, Utah-Audrey Camp netted four goals and the Millard Eagles pounded Maeser Prep 6-2 in non-region girls soccer action Thursday. Heidi Thurman also scored in the win for Millard.RICHFIELD, Utah-Kate Robinson and Melissa Crane each scored twice as the Richfield Wildcats smacked Beaver 6-0 Thursday in non-region girls soccer action. Brittan Tait and Nora Foster also scored in the win for Richfield, while Megan Terry posted the shutout for the Beavers.Girls VolleyballRegion 20TROPIC, Utah-Milford won the first set 25-15 then rolled to a straight set win over Bryce Valley with 25-8 and 25-11 wins in the final two sets in Region 20 volleyball Thursday.Non-RegionGUNNISON, Utah-The Gunnison Valley Bulldogs prevailed over Beaver in straight sets 3-0 in non-region volleyball action Thursday. The Bulldogs won 25-20, 25-14 and 25-20.NEPHI, Utah-The Carbon Dinos routed Juab 3-0 Thursday in non-region volleyball action. The Dinos prevailed 25-13, 25-21 and 25-22.ENTERPRISE, Utah-The Enterprise Wolves bested the North Sevier Wolves 3-0 Thurday in non-region volleyball action. Enterprise netted wins of 25-19, 25-19, 25-19.RICHFIELD, Utah-The Richfield Wildcats responded from an 0-1 deficit by winning the next three sets in a 3-1 win over the Panguitch Bobcats in non-region volleyball action Thursday. The Wildcats prevailed 15-25, 27-25, 25-17, 31-29.ALTAMONT, Utah-The Millard Eagles hit the road and swept the Altamont Longhorns 3-0 in non-region volleyball action Thursday.MONROE, Utah-South Sevier took the first set 25-21, before North Sanpete stormed back to win three close sets in a row, 25-12, 25-23, 25-23 to win the match 3-1 in non-region volleyball Thursday.Boys GolfRegion 12FERRON, Utah-Luke Williams went low with a 71 to lead Grand to victory at the Region 12 golf tournament Thursday at Millsite in Emery County. The Red Devils shot a 317 as a team, Richfield placed second with a 323, while Carbon finished third with a 327. South Sevier placed fourth with a 363, Emery took fifth on their home course with a 376 and San Juan finished sixth by shooting a 403.Grand’s Williams won the individual title with his 71, his teammate Rafe Saunders and Carbon’s Bode Salas tied for second with a 75, Jaren Anderson of Richfield placed fourth with a 76, his teammate TJ Gadd and Carbon’s Nick Olsen tied for fifth by each shooting a 78. Tags: Audrey Camp/Josephine Kay/Katie Cowan/Katie Larsen August 22, 2019 /Sports News – Local Prep Sports Roundup: 8/22 Brad Jameslast_img read more

BREAKING: Some students won’t return to university until February

first_imgSubjects starting later, according to the BBC, will include “English literature, history and maths”. By 7 February, all students should have returned. It is not yet clear how these plans will be implemented at the University of Oxford. Image Credit: Pixabay. The Department for Education, outlining plans for returning to universities in England after Christmas, has asked that institutions stagger the return of students over five weeks in order to “ensure the safety of students and staff”. Michelle Donelan, the universities minister, said when announcing the plans: “The health and wellbeing of students, staff and local communities is always our primary concern and this plan will enable a safer return for all students. “But we must do this in a way which minimises the risk of transmission. I know students have had to make sacrifices this year and have faced a number of challenges, but this staggered return will help to protect students, staff and communities.”center_img This is a developing story. It will be updated as further information is provided. Students will also be offered two lateral flow tests when they arrive back, echoing the current optional lateral flow tests provided for students as they leave for the Christmas vacation. Speaking regarding these tests, Health Secretary Matt Hancock said: “I encourage all students to play their part in bringing this virus under control by getting tested twice, and by following the restrictions in place when travelling to and from university this term.” UCU general secretary Jo Grady said: “This is a step forward, but plans for next term still pose a risk to staff and student safety. Universities must work with the government to support students who decide the reality of life on campus during this pandemic isn’t for them, including releasing them from accommodation contracts.” Students who will be prioritised for an early return include those on placements or practical courses with a need for in-person teaching (including music, dance, drama, the sciences, medicine, nursing and dentistry).last_img read more

Anti-bullying film to be shown in Union City

first_imgUNION CITY — “Alone with the Darkness,” a short powerful anti-bullying film directed by Frank Gigante, will be shown Thursday night, Feb. 15. Free event and free parking.7:30 p.m. at the Union City performing arts Center 2500 Kennedy Blvd. Free parking at 23rd street parking deck located on 23rd between Summit and Kerrigan Avenues.last_img

Speech: Strengthening financial oversight of Montenegrin Parliament

first_imgCopyright: Parliament of MontenegroI’m delighted that the British Government, working through the Westminster Foundation for Democracy, has supported the establishment of a Parliamentary Budget Office within the Parliament of Montenegro. The UK’s intention is that this facility will enhance the culture of effective financial oversight and scrutiny, thus assisting the country in the process of European integration.We are grateful to the Parliament of Montenegro for their consistent support for this project, which was not an easy task, and involved a series of complicated institutional and procedural solutions.The work of the Montenegrin Parliamentary Budget Office has been tested through the times of the post-election period in 2016, formation of the new Government, adoption of Montenegro’s first 4-year Fiscal Strategy and the government’s plan for fiscal consolidation.Although few in numbers, the researchers have managed to both build up their capacities and answer the inquiries of MPs, as well as work proactively on the topics they considered neglected or important enough for the attention of MPs.While the position of the UK remains that we call for all elected MPs to take up their seats in Parliament and in order to better serve those who voted for them, I am pleased that MPs of all parties have drawn on material produced by the Parliamentary Budget Office.We are particularly glad that within this project, the MPs and parliamentary staff of the Montenegrin Parliament had the opportunity to witness the work done by the Scottish Parliament Information Centre and the functioning of its Financial Scrutiny Unit.The UK looks forward to the Parliament of Montenegro continuing to develop the Parliamentary Budget Office. There is still work to do to make the Parliamentary Budget Office an integral part of the parliamentary structure, and I welcome the reassurance from the Parliamentary leadership that this will happen soon.The UK hopes that the products produced by the Parliamentary Budget Office will be used not only by the MPs in the Committee for Economy, Finance and Budget, but by all the committees across the Parliament. Public money flows through all policies of the state, and its oversight is equally important in the welfare sector as well as healthcare or education.Furthermore, we hope that the products of Parliamentary Budget Office will be read and used by a wider audience outside of the Parliament, as a credible and objective source of data for both the civil society organisations and media.The UK stands ready to support the future work to strengthen the accountability of Montenegrin institutions, and to continue work which draws on the UK’s rich parliamentary experience.Zahvaljujem se na vašem doprinosu i radujem nastavku razgovora na ovu temu.Hvala. Poštovani gospodine Sekuliću, gospodine Jovićeviću, dragi Emile, poštovani poslanici i poslanice,Drago mi je da sam danas ovdje sa vama da obilježimo kraj faze projekta na kojem smo radili sa crnogorskom Skupštinom i Vestminsterskom Fondacijom.As the representative body of Montenegrin citizens, and the seat of legislative power in the country, ensuring sound legislative scrutiny is central to Parliament’s role and essential in delivering accountability. Robust parliamentary oversight of the public finances not only facilitates good use of public funds but enhances the provision of public services and supports the alignment of policy with citizens’ needs.Parliamentary Budget Offices, such as the one the UK has helped the Montenegrin Parliament to establish, are designed to enhance the financial and economic analytical expertise available within a parliament as well as providing independent costing of policies and legislation. They are supposed to be the objective and competent aide to the MPs in performing one of their most crucial roles — holding government accountable for the money it has spent. read more

Press release: £1.3 billion industry/government investment in UK economy and new partnership driving early disease detection

first_img I want the UK to have the most advanced health and care system on the planet. Technology and artificial intelligence have the potential to revolutionise healthcare by unlocking the next generation of treatments, diagnosing diseases before symptoms appear and helping patients take greater control of their own health. Our world-leading plans to map 100,000 genomes is just one example of how innovation can deliver life-changing results for patients and we want to build on its success to provide patients with truly personalised care. Tens of thousands of lives could be saved by pioneering research to detect deadly diseases before symptoms even appear, thanks to a new collaboration between the government and the Life Sciences Industry. The deal will also announce that global biopharmaceutical company UCB is investing £1 billion in research and development, including in a new state-of-the-art facility, continuing the UK’s reputation as a world leading base for global life sciences research and industry.The programme, backed by up to £79 million of government funding, will study 5 million healthy people to develop new diagnostic tests using AI and is part of the government’s Life Science’s Sector Deal 2, announced today by Businesses Secretary Greg Clark and Health Secretary Matt Hancock. View the Life Science Sector Deal 2. The programme – Accelerating Detection of Disease – will be led by Professor Sir John Bell and brings together the NHS, industry and leading charities including Cancer Research UK, the British Heart Foundation and Alzheimer’s Research UK. It will be the largest ever study of its kind collecting such a range of data from healthy volunteers over years. This will help deliver the Early Diagnosis Mission — a key part of the Industrial Strategy’s AI and Data Grand Challenge. Businesses will be able to access this funding through UKRI managed competitions.Researchers will study how the group’s health changes, identifying common characteristics to understand how and why diseases develop. The ambition is to empower everyone to understand their risk of developing diseases and take steps to remain healthy for longer. The project will attract investment from global life science companies seeking to develop new diagnostic tools and treatments.It is estimated that if late stage diagnosis were halved across bowel, ovary, prostate and lung cancer, over 55,500 more people would be diagnosed at an early stage, potentially resulting in 22,500 fewer deaths per year within 5 years of diagnosis.In a meeting with industry leaders at No10, the Business Secretary announced that as part of the Sector Deal a new £150-200 million research and development facility of global biopharmaceutical company UCB will be built in the UK as part of a total investment of around £1 billion over the next 5 years. The transition to this state-of-the-art facility will support around 650 jobs and further boost the UK’s reputation for developing world-leading medical treatments and technologies.Health Secretary Matt Hancock said: From the first vaccine to the discovery of DNA, the UK has always been at the forefront of medical endeavour and healthcare innovations. That is why we are building on our unique strengths by placing life sciences at the centre of our modern Industrial Strategy, backed by the biggest increase in public research and development investment in UK history. This is our modern Industrial Strategy in action as we work hand in hand with industry to ensure the UK remains the go-to destination for launching new businesses, new discoveries and treatments to benefit health around the world. The announcement of UCB’s investment in new research and development is a clear vote of confidence in UK life sciences research base and business. kick-starting the largest whole genome sequencing project ever undertaken, helping to develop new tests and treatments for cancer and rare diseases establishing a network of 5 centres of excellence in digital pathology and radiology to supercharge new diagnostic industries Implementing the Accelerated Access Review with government, industry, the NHS and its partners working together to put NHS patients at the forefront of the latest advances in healthcare This Sector Deal is another major step forward for the Life Sciences Industrial Strategy in the UK. It has been hugely enabled by government and will initiate new projects that will be a magnet for further investment. Together, industry, charities, government and the NHS can tackle some of the major challenges to healthcare systems, including ageing and early diagnostics and, in doing so, can grow the economy and demonstrate what a modern Industrial Strategy looks like in action. The UK remains the leading destination for life sciences inward investment in Europe, second only to the US globally. Major global companies continue to commit to the UK as an investment and operating location. At home we are also nurturing the next crop of global businesses and future exporters, such as the companies in our thriving cell and gene therapy industry. Last year the UK exported around £30 billion in life sciences products – there is worldwide demand for our innovative products and our excellent services. As an international economic department, our role is to promote the UK abroad, capitalising on the demand for our goods and services and drive investment into our industries. Our team of HM Trade Commissioners and overseas network are based in 108 markets, providing a vital link for businesses as we seek to make the most of opportunities presented by leaving the European Union. At UCB, we are proud of our heritage in the UK and I am very pleased to announce our planned investment to support the construction of a major R&D hub in the UK, which will enable us to build upon our numerous active collaborations with UK universities, biotechs and medical research charities, and continue our successful track record of bringing innovative medicines discovered in the UK to patients globally Access to world class talent remains vital to R&D and we therefore look forward to working closely with government to support the full implementation of Sir John Bell’s Life Sciences Industrial Strategy, and importantly, to ensure that patients in the UK have quicker access to the innovative medicines researched and developed here. Professor Sir John Bell said:center_img life-saving early disease detection technology to be developed by new partnership between government and industry using artificial intelligence (AI) to develop the next generation of treatments, including a first-of-its-kind national health programme the second Life Sciences Sector Deal, with industry investment from 10 companies, will support healthcare innovation and back businesses to create high-paid, high-quality jobs as part of the government’s modern Industrial Strategy the deal signals a vote of confidence in UK industry, with global biopharmaceutical company UCB investing around £1 billion in research and development, including in a new state-of-the-art facility Secretary of State for International Trade, Dr Liam Fox MP said: Jean-Christophe Tellier, Chief Executive Officer at UCB, said: Other new announcements as part of the Life Sciences Sector Deal include: A further £30 million investment in the UK by healthcare company Roche, including a £20 million investment over 3 years in a precision cancer research partnership with the Christie NHS Foundation Trust in Manchester. This will use cutting-edge genomic technology and big data to accelerate the next generation of digital clinical trials for rare cancers, making the UK a leading global hub for rare cancer trials, potentially benefiting nearly 5,000 patients annually Measures to further strengthen the UK environment for clinical research, including through IQVIA investing £24 million facilitated by the National Institute for Health Research in a Prime Site for clinical trials across the North of England, and IQVIA and Genomics England announcing a new £20 million partnership to enable more efficient drug research and support accelerated discovery of personalised medicines for NHS patients Over £80 million of investment in the UK from 5 rapidly growing cell and gene therapy companies. The majority of this investment will be in cutting-edge manufacturing facilities, building on the government investment in advanced therapies manufacturing made in last years’ Sector Deal. Autolus have planned to invest a further £50 million to expand its UK presence, including a new global headquarters with laboratories in White City. Oxford BioMedica, Cobra Biologics, and Roslin CT are planning investments of £19 million, £8 million, and £4 million respectively to scale up their UK cell and gene therapy manufacturing facilities. Bellicum, an inward investor, has committed to its first European investment in the UK with £2 million and 20 jobs initially. Today’s announcement builds on the first Life Sciences Sector Deal, published in December 2017. The deal committed nearly £500 million of government investment into UK life sciences, backed by more than £1 billion of private sector investment, to build on the sector’s strengths, help to secure thousands of jobs and ensure that new medicines and technologies are created in the UK.In the last year its achievements have included: The deal, which brings together 10 companies and is backed by wide range of organisations from across the sector, includes more than £1.3 billion of investment between the public and private sectors. It ensures the UK remains in pole position in the treatments of today, while creating the industries and treatments of the future such as genomics and AI-powered diagnosis.Business Secretary Greg Clark said: It has also been announced today, through the Strategic Priorities Fund, that research programmes will be awarded over £35 million to boost medical science. The first programme will seek to better understand tissue development through the Human Cell Atlas initiative, whilst the second will bring together the physics and biology communities to address key questions in biological and biomedical sciences.The new Life Sciences Sector Deal further strengthens the UK’s world-leading capabilities in the likes of genomic science, Big Data assets and gene and cell therapies, ensuring we are at the forefront of new industries in areas such as genomics and AI-driven diagnostics.The UK remains the number 1 destination for life sciences inward investment in Europe, ranks number 2 globally behind the US, and has also grown a thriving domestic industry with more than 5,600 companies supporting 240,000 jobs and generating a turnover of around £70 billion per year. All of the top 25 global pharmaceutical companies, and the top 30 global medical technology companies, operate in the UK. The UK also accounts for 12% of total life sciences academic citations and 18% of the most-cited publications – the second highest share above China, Germany and Canada.Notes to editorsThe up to £79 million Accelerating Detection of Disease programme will be delivered by UK Research and Innovation through the Industrial Strategy Challenge Fund, subject to business case approval and match funding from industry.UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases in immunology or neurology. The investment around £1 billion over the next 5 years will include £150-200 million to build a new, purpose-built state-of-the-art facility enabling cutting-edge R&D, early manufacturing and commercial operations. The transition to this new facility will support around 650 high-skilled jobs, mainly in scientific research and early manufacturing. The investment will allow UCB to continue their innovative research in areas of unmet patient need, deepen their collaborations with UK organisations, and solidify their position as a leader in UK life sciences. UCB’s new facilities will be based in or close to the wider Slough area and will be announced subject to UCB finalising their search for a suitable location and agreed contractual negotiations.The Ageing Society mission with the modern Industrial Strategy is to ensure that people can enjoy at least 5 extra healthy, independent years of life by 2035, while narrowing the gap between the experience of the richest and poorest.It is estimated that by 2033 if late stage diagnosis were reduced by 50% across bowel, ovary, prostate and lung cancer, over 55,500 more people would be diagnosed at an early stage, which could result in over 22,500 fewer deaths per year within 5 years of diagnosis. This is calculated by Cancer Research UK based on current distribution of stage at diagnosis for cancers with a recorded stage of disease in England (obtained from Public Health England), cancer incidence projections for 2033 and estimates for 5-year cancer survival by stage.Using data, artificial intelligence and innovation to transform the prevention, early diagnosis and treatment of chronic diseases is the first mission of the AI and Data Grand Challenge. Success in this mission is one of a number of steps towards saving lives and increasing NHS efficiency by enabling earlier diagnosis and reducing the need for costly late stage treatment. The opportunity – working with academia, the charitable sector, and industry and harnessing the power of AI and data technologies – is considerable. It should lead to a whole new industry of diagnostic and tech companies which would drive UK economic growth.The Accelerating Detection of Disease project also supports the Ageing Society Grand Challenge mission, which is to ensure that people can enjoy at least 5 extra healthy, independent years of life by 2035, while narrowing the gap between the experience of the richest and poorest.last_img read more

BAKO holds interactive workshop for bakers

first_imgOn 24 July BAKO North Western hosted an interactive workshop for bakers to learn about marketing and social media.The free workshop, held in association with Delineo, concentrated on improving POS skills, as well as using social media to expand their businesses.The day covered the theoretical side of marketing, such as developing a brand, as well as practical tips on how to construct a plan using a simple calendar or events and planning products and promotions around them.Sam Hayward, BAKO marketing executive and event organiser, said: “By holding this workshop we can help our customers expand their skills and knowledge – by helping them improve the marketing activities they are already undertaking, but not necessarily achieving the greatest results, and showing them that social media is an easy, interactive way to both engage with existing customers and find new ones, with very little time or cost.”last_img read more

Harris + Hoole opens first airport site

first_imgTesco backed coffee shop, Harris + Hoole is to open in its first airport location at Stansted Airport.The opening is part of the airport’s second phase of an £80m development of its departure lounge- and will take the business’ total shop numbers to 46 since it started in 2012.This comes as speculation builds around the future of the coffee shop in Tesco stores, after the supermarket boss in charge of in-store restaurants and coffee shops, such as Harris + Hoole, left the business as part of its restructuring plans.Nick Tolley, Harris+Hoole’s chief executive said: “We beat over 70 tenders to win a unit in Stansted’s redeveloped departure lounge, so this launch is a real coup for us. Our focus at the moment is making our Stansted store a success.“Airports are new to us, so it will require real team work, but I’m confident we’ve got the best people on the job. As for opening more stores in travel hubs and airports, the opportunity has to be right, but it’s certainly not something we’re ruling out.”The shop will cater for eat-in and food-to-go needs, and it has launched an app that enables customers to check-in to the store and pre-order to appeal to time-pressured customers.last_img read more